#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infantile spasms Microvillous inclusion disease Soft tissue necrosis Biliary cancer metastatic Hypoparathyroidism Neoplasm malignant Chorioretinitis Ocular lymphoma Ischaemic stroke Alveolar rhabdomyosarcoma Osteomyelitis Keratosis follicular Arrhythmogenic right ventricular dysplasia Angiosarcoma non-metastatic Arrhythmia More trials…

    Learn about Rare Diseases

    Fragile X syndrome – Life with Disease Haemolytic uraemic syndrome – Treatment Haemophilia – Life with Disease Synovial sarcoma – Diagnostics Angiosarcoma non-metastatic – Life with Disease Hyperoxaluria – Diagnostics Methylmalonic acidaemia – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) Glycogen storage disease type V – Treatment Myxofibrosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mepolizumab Acetylsalicylic Acid Anhydrous Cholestyramine Masofaniten SODIUM SELENITE PENTAHYDRATE Tildacerfont INOBRODIB Lufepirsen Cefazolin HYALURONIDASE Plerixafor Iohexol Nortriptyline Vepdegestrant CHOLINE ALFOSCERATE Burfiralimab Ondansetron Lactose Monohydrate Magnesium Citrate Ephedrine Hydrochloride More therapies…

    Learn about Your Condition

    Senile dementia Malignant mast cell neoplasm Anxiety Femur fracture Iron overload Mitral valve incompetence Friedreich's ataxia Migraine Herpes simplex reactivation Sciatica Petit mal epilepsy Cardiac amyloidosis Oesophageal atresia Anal cancer stage III Glioblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study Comparing Lidocaine Gel and Tetracaine/Oxybuprocaine Eye Drops for Glaucoma Patients Undergoing Outpatient Needling Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glaucoma
    Investigated Drugs:
    • Anhydrous Lidocaine Hydrochloride
    • Oxybuprocaine Hydrochloride
    • Tetracaine Hydrochloride
    Spain

  • Study on Hexaminolevulinate for Patients with Non-Muscle Invasive Bladder Cancer to Reduce Need for Second Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Bladder transitional cell carcinoma recurrent
    • Bladder transitional cell carcinoma stage 0
    • Bladder transitional cell carcinoma stage I
    Investigated Drugs:
    • Hexaminolevulinate
    Italy

  • Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Glioblastoma
    Austria Belgium Czechia Denmark France Germany +4

  • Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Thalassaemia
    • Primary myelofibrosis
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Luspatercept
    Bulgaria France Germany Greece Italy The Netherlands +2

  • Study Comparing Quinidine and Verapamil for Patients with Short-Coupled Idiopathic Ventricular Fibrillation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ventricular fibrillation
    Investigated Drugs:
    • Verapamil
    The Netherlands

  • Study on Fasudil Hydrochloride for Memory Loss Prevention in Early Alzheimer’s Disease Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Fasudil Hydrochloride
    Norway
Previous Page
1 … 439 440 441 442 443 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!